GlassScriptPhysician profile
Natalie G Miller
NPI 1144678566
$2,223.08
in general payments reported to CMS, 2019-2025
17 companies · $36.49 in 2025
The $36.49 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $300 · 2023: $799 · 2024: $1,087 · 2025: $36.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,923.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $658.24 | 2023-2024 | Ztlido |
| Nevro Corp. | $349.83 | 2022-2024 | Senza |
| Abbvie INC. | $290.65 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $235.84 | 2022-2024 | Belbuca, Xtampza |
| Lilly USA, LLC | $187.05 | 2023-2024 | Emgality, Reyvow |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.49 | 2022-2024 | Relistor |
| Novartis Pharmaceuticals Corporation | $92.62 | 2023-2024 | |
| Ucb, INC. | $55.42 | 2024 | Briviact |
| Biohaven Pharmaceutical Holding Company LTD. | $51.81 | 2022 | |
| Valinor Pharma, LLC | $44.86 | 2023-2024 | Movantik |
| Pfizer INC. | $30.01 | 2023 | |
| Amgen INC. | $28.13 | 2022 | |
| Alexion Pharmaceuticals, INC. | $25.99 | 2023 | Ultomiris |
| Neurocrine Biosciences, INC. | $20.99 | 2024 | Ingrezza |
| Currax Pharmaceuticals LLC | $14.65 | 2024 | Onzetra Xsail |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $14.48 | 2023 | Inspire |
| Emd Serono, INC. | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.